Verona Pharma ( (VRNA) ) has released its Q4 earnings. Here is a breakdown of the information Verona Pharma presented to its investors.
Verona Pharma, a biopharmaceutical company, focuses on developing and commercializing innovative therapies for chronic respiratory diseases, with its first product, Ohtuvayre, targeting the maintenance treatment of COPD.